Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.
about
Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@ast
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@en
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@nl
type
label
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@ast
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@en
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@nl
prefLabel
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@ast
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@en
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@nl
P2093
P2860
P356
P1476
Levofloxacin-ceftriaxone combi ...... of pneumolysin and autolysin.
@en
P2093
Aritra Bhattacharyya
Arnab Majhi
Biswadev Bishayi
Rana Adhikary
Sayantika Mahanti
P2860
P304
P356
10.1128/AAC.03245-14
P407
P577
2014-06-23T00:00:00Z